If these vaccines, particularly those potentially capable to elicit efficient virus-specific CD8+ T cells, can also act as therapeutic vaccines in patients with active infection, is a challenging question, despite the experience with therapeutic vaccines against chronic viral infections are not encouraging. The gene discussed is CD8A; the disease is infection.